home / stock / bysi / bysi news

BYSI News and Press, BeyondSpring Inc.

Stock Information
Company Name: BeyondSpring Inc.
Stock Symbol: BYSI
Market: NASDAQ
Website: beyondspringpharma.com
Menu
BYSI BYSI Quote BYSI Short BYSI News BYSI Articles BYSI Message Board
Get BYSI Alerts

News, Short Squeeze, Breakout and More Instantly...
BYSI - Expected US Company Earnings on Monday, July 29th, 2024

COPT Defense Properties of Beneficial Interest (CDP) is expected to report $0.64 for Q2 2024 Bank of Marin Bancorp (BMRC) is expected to report $0.19 for Q2 2024 Oak Ridge Financial Services Inc (BKOR) is expected to report for Q2 2024 D/B/A Centerspace (CSR) is expected to report $1....
BYSI - BeyondSpring files to offer up to 10M ordinary shares

2024-06-12 17:32:14 ET More on BeyondSpring Financial information for BeyondSpring Read the full article on Seeking Alpha For further details see: BeyondSpring files to offer up to 10M ordinary shares

BYSI - US Companies Moving the Markets, Evening edition
Thu, May 23, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...

BYSI - BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics

FLORHAM PARK, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it hosted a virtua...
BYSI - BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics

FLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced it will host a Research...

BYSI - BeyondSpring GAAP EPS of -$1.64, revenue of $1.35M

2024-04-30 04:53:12 ET More on BeyondSpring Financial information for BeyondSpring Read the full article on Seeking Alpha For further details see: BeyondSpring GAAP EPS of -$1.64, revenue of $1.35M

BYSI - BeyondSpring GAAP EPS of -$0.54, revenue of $1.75M

2024-04-30 04:53:12 ET More on BeyondSpring Financial information for BeyondSpring Read the full article on Seeking Alpha For further details see: BeyondSpring GAAP EPS of -$0.54, revenue of $1.75M
BYSI - BeyondSpring Files 2023 Annual Report on Form 20-F

FLORHAM PARK, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it has filed its...

BYSI - Expected US Company Earnings on Tuesday, April 16th, 2024

All For One Media Corp (AFOM) is expected to report for quarter end 2023-12-31 Omnicom Group Inc. (OMC) is expected to report $1.52 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Commerce Bancshares Inc. (CBSH) is expected to report $0...

BYSI - Expected earnings - BeyondSpring Inc.

BeyondSpring Inc. (BYSI) is expected to report for quarter end 2023-12-31
Next 10